NASDAQ: RZLT - Rezolute, Inc.

Yield per half year: +196.15%
Sector: Healthcare

Share chart Rezolute, Inc.


About

Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc.

More details
and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.

Main settings

EBITDA -0.0255
Число акций ао 0.05119 млрд
P/BV 10.04
EV/EBITDA -0.2369
Цена ао 2.12
ISIN US76200L3096
Сайт https://www.rezolutebio.com
Change price per day: 0% (3.08)
Change price per week: +23.2% (2.5)
Change price per month: +73.03% (1.78)
Change price per 3 month: +204.95% (1.01)
Change price per half year: +196.15% (1.04)
Change price per year: +50.24% (2.05)
Change price per year to date: +242.22% (0.9)


All parameters ⇨

Grade

Underestimation

Title Value Grade
P/S 0 0
P/BV 10.04 9
P/E 0 0
EV/EBITDA -0.2369 0
Total:

Efficiency

Title Value Grade
ROA, % -37.51 0
ROE, % -38.99 0
Total:

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total:

Debt

Title Value Grade
Debt/EBITDA -0.0483 10
Total:

Growth impulse

Title Value Grade
Profit growth, % -750.8 0
Share price growth, % 0 0
Dividend growth, % 0 0
Total:

Main owners

Institutions Volume Share, %
Federated Hermes, Inc. 10154327 0
Vivo Capital, LLC 3242842 38.52
Nantahala Capital Management, LLC 3075414 36.53
Stonepine Capital Management, LLC 2768656 32.89
First Manhattan Company 2680978 31.85
Blackstone Inc 1537684 18.27
Vanguard Group Inc 1407652 16.72
Caxton Corporation 1318967 15.67
Sphera Funds Management Ltd. 996710 11.84
Adage Capital Partners GP L.L.C. 631690 7.5

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Nevan Charles Elam J.D. Founder, CEO & Acting Chairman of the Board 973.65k 1967 (57 years)
Dr. Brian Kenneth Roberts M.D. Chief Medical Officer 738.86k 1976 (48 years)
Dr. Davelyn Eaves Hood M.B.A., M.D. Director and Head of Scientific & Patient Affairs N/A
Mr. Michael R. Deperro Senior VP & Head of Corporate Development N/A
Mr. Michael Covarrubias Senior VP & Head of Program & Portfolio Management N/A
Mr. Chris Milks VP & Head of Finance N/A
Dr. Raj Agrawal M.D. VP & Head of Ophthalmological Clinical Development N/A
Ms. Robyn Sweinhart VP & Head of Quality N/A
Ms. Erin O'Boyle Senior VP & Head of Clinical Operations N/A
Mr. Daron G. Evans M.B.A., M.S. Chief Financial Officer N/A 1974 (50 years)

About company

Address: United States, Redwood City. CA, 201 Redwood Shores Parkway - open in Google maps, open in Yandex maps
Website: https://www.rezolutebio.com
Phone: +tel:6502064507